Skip to content
Government Federal, Medical Health Aged Care

Audit Committee Public Hearing: Procurement at Services Australia and the NDIA

House of Representatives' < 1 mins read

The Joint Committee of Public Accounts and Audit (JCPAA) will hold a public hearing this afternoon for its inquiry into a series of procurements conducted by Services Australia and the NDIA which were connected with consulting firm Synergy 360.

The hearing will feature Infosys technologies, a firm mentioned in the media reporting that led to the Independent Review of Services Australia and NDIA Procurement and Contracting (the Watt Review).

​Committee Chair, Mr Julian Hill MP, said that the Committee is examining the expenditure of public funds at the NDIA and Services Australia, as well as the conduct of parties associated with procurements by those agencies.

“The Committee considers that the serious problems with these procurements identified by the Watt Review warrant thorough investigation and will leave no stone unturned.”

Details for the public hearing are:

Date: Friday 23 June 2023
Time: 3.15pm – 5.00pm AEST
Location: Committee Room 2R1, Parliament House, Canberra.

The hearing will be broadcast on the APH Website.

Further information is available on the inquiry website.

Media inquiries

Mr Julian Hill MP, Chair of the Joint Committee of Public Accounts and Audit on
(03) 9791 7770 (Electorate Office).

For background information

Committee Secretariat
02 6277 4615
jcpaa@aph.gov.au

For more information about this Committee, you can visit its website. On the site, you can make a submission to an inquiry, read other submissions, and get details for upcoming public hearings. You can also track the Committee and receive email updates by clicking on the blue ‘Track Committee’ button in the bottom right-hand corner of the page.

More from this category

  • Energy, Government Federal
  • 14/09/2024
  • 15:37
Friends of the Earth

CHEVRON PUTS LIPSTICK ON PIGS

CHEVRON’S GREEN WASHING HIGH FARCE Plan to put lipstick on a pig It’s not a joke, though, at first glance, it looks like one.…

  • Contains:
  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.